Deloitte releases Mid-Year Life Sciences Outlook 2026
Executives report they are prioritizing growth discipline, AI value proof and resilience in the second half of 2026
Executives report they are prioritizing growth discipline, AI value proof and resilience in the second half of 2026
Nearly all respondents expect rising costs due to trade policies.
The pullback in spending, Deloitte found, reflects a mix of cost pressures and caution amid a higher cost of living.
The consulting firm expects total sales between November and January to reach $1.61 trillion to $1.62 trillion, up from $1.57 trillion during the 2024 holiday period.
The report underscores how despite a decline in inflation, consumers’ perceptions of price and value haven't recovered, leading to more widespread value-conscious behavior.
Seasonal shoppers focus on deals to make the most of every festive dollar this season.